MedPath

VAI pilot studie in glioblastome

Conditions
Glioblastoma, GlioblastoomBrain tumour, hersentumor
Registration Number
NL-OMON21865
Lead Sponsor
niversity Medical Center Groningen (departments of radiology and ngmb)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Histological confirmed glioblastoma after standard treatment

- New contrast enhancing lesion on follow-up MRI

Exclusion Criteria

- Minors (<18 years)

- Residual enhancement on post-operative MRI

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is to establish the practicability abd diagnostic accuracy of VAI-MRI for the treatment evaluation of glioblastoma.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath